1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

CardioDx, Inc.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2004

Location

Redwood City CA US

Primary Industry

Biotechnology

About

Established in 2004 and based in California, US, CardioDx, Inc. operates as a developer of genomic tests to individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias and heart failure.
Current Investors
Kleiner Perkins, Mohr Davidow Ventures, TPG Biotech

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Cardiology
Verticals
HealthTech
Company Stage
Ceased Operations
Total Amount Raised
Subscriber access only

Key Contacts

Name Position Start Date End Date Vcard Bio
Board Member BM
BM Board Member
Name Firm Deal Date Number Of Deals Vcard
AI LP
AI LP
AI Active Investor LP Lead Provider

Want to see more?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.